Efavirenz dose reduction to 200 mg once daily in a patient treated with rifampicin

AIDS. 2009 Mar 27;23(6):742-4. doi: 10.1097/QAD.0b013e32832914a3.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • AIDS-Related Opportunistic Infections / drug therapy*
  • Alkynes
  • Anti-HIV Agents / adverse effects*
  • Antibiotics, Antitubercular / therapeutic use
  • Benzoxazines / adverse effects*
  • Cyclopropanes
  • Drug Interactions
  • Humans
  • Male
  • Middle Aged
  • Rifampin / therapeutic use*
  • Tuberculosis / drug therapy*

Substances

  • Alkynes
  • Anti-HIV Agents
  • Antibiotics, Antitubercular
  • Benzoxazines
  • Cyclopropanes
  • efavirenz
  • Rifampin